Website review cancerresearchhorizons.com
Cancer Research Horizons
Generated on April 02 2026 07:09 AM
Old data? UPDATE !
The score is 66/100
SEO Content
Title
Cancer Research Horizons
Length : 24
Perfect, your title contains between 10 and 70 characters.
Description
We are a specialist drug discovery, development and commercialisation company, taking cutting edge innovations from the lab bench to the bedside, translating them into effective treatments and diagnostics for cancer patients.
Length : 225
Ideally, your meta description should contain between 70 and 160 characters (spaces included). Use this free tool to calculate text length.
Keywords
Very bad. We haven't found meta keywords on your page. Use this free online meta tags generator to create keywords.
Og Meta Properties
Good, your page take advantage of Og Properties.
| Property | Content |
|---|---|
| site_name | Cancer Research Horizons |
| url | https://www.cancerresearchhorizons.com/home-page |
| title | Home page |
| description | We are a specialist drug discovery, development and commercialisation company, taking cutting edge innovations from the lab bench to the bedside, translating them into effective treatments and diagnostics for cancer patients. |
| image | https://www.cancerresearchhorizons.com/sites/default/files/styles/uncropped_large/public/2024-08/2023.05.22_CancerResearchHorizons_0285.jpg?itok=Gh4yhTOU |
Headings
| H1 | H2 | H3 | H4 | H5 | H6 |
| 1 | 8 | 19 | 0 | 0 | 0 |
- [H1] Our business is breakthroughs
- [H2] Main navigation
- [H2] Innovate and work with us
- [H2] Latest news
- [H2] Our portfolio
- [H2] Connect with us
- [H2] Social links
- [H2] Key links
- [H2] Address
- [H3] 14
- [H3] £600m+
- [H3] 150+
- [H3] 90+
- [H3] £3.45bn+
- [H3] Researchers
- [H3] Partners
- [H3] Investors
- [H3] C-Further unveils first therapeutic programmes dedicated to paediatric oncology
- [H3] In search of the missing link
- [H3] The cutting-edge of translational oncology - directly to your inbox
- [H3] Cancer Research UK and NovalGen dose the first patient in the Phase 1 trial of T-cell engager NVG-222
- [H3] Laigo Bio completes final close of oversubscribed seed financing of €17 million co-led by Biovance Capital and Kurma Partners to advance oncology and auto-immunity programs
- [H3] C-Further unveils first therapeutic programmes dedicated to paediatric oncology
- [H3] Artios receives US FDA Fast Track Designation for DNA polymerase theta (Polθ) inhibitor ART6043 for treatment of gBRCA-mutated HER2-negative breast cancer
- [H3] Drug discovery and development capabilities
- [H3] Explore our pipeline
- [H3] Licensing opportunities
- [H3] Our start-up portfolio
Images
We found 31 images on this web page.
Good, most or all of your images have alt attributes.
Text/HTML Ratio
Ratio : 16%
Good, this page's ratio of text to HTML code is higher than 15, but lower than 25 percent.
Flash
Perfect, no Flash content has been detected on this page.
Iframe
Too Bad, you have Iframes on the web pages, this mean that content in an Iframe cannot be indexed.
SEO Links
URL Rewrite
Good. Your links looks friendly!
Underscores in the URLs
Perfect! No underscores detected in your URLs.
In-page links
We found a total of 48 links including 0 link(s) to files
| Anchor | Type | Juice |
|---|---|---|
| Our people | Internal | Passing Juice |
| Our boards | Internal | Passing Juice |
| Our impact | Internal | Passing Juice |
| Our reports and corporate responsibility | Internal | Passing Juice |
| Our expert network | Internal | Passing Juice |
| Careers | Internal | Passing Juice |
| Protect your innovation | Internal | Passing Juice |
| Entrepreneurial training | Internal | Passing Juice |
| Access funding | Internal | Passing Juice |
| Set up and build your start-up | Internal | Passing Juice |
| Translational science | Internal | Passing Juice |
| Our community | Internal | Passing Juice |
| Our partnerships | Internal | Passing Juice |
| Our start-up portfolio | Internal | Passing Juice |
| Our pipeline | Internal | Passing Juice |
| Licensing opportunities | Internal | Passing Juice |
| Access multi-modal cancer datasets | Internal | Passing Juice |
| Medtech and diagnostics | Internal | Passing Juice |
| Our Seed Fund | Internal | Passing Juice |
| Donating to the Cancer Impact Booster | Internal | Passing Juice |
| Our drug discovery science | Internal | Passing Juice |
| Functional Genomics Centre | Internal | Passing Juice |
| Centre for Drug Development | Internal | Passing Juice |
| Research tools | Internal | Passing Juice |
| Our data portfolio | Internal | Passing Juice |
| Our success stories | Internal | Passing Juice |
| Our news | Internal | Passing Juice |
| Our articles | Internal | Passing Juice |
| Our media | Internal | Passing Juice |
| Events | Internal | Passing Juice |
| Find out more | Internal | Passing Juice |
| Learn more | Internal | Passing Juice |
| Learn more | Internal | Passing Juice |
| Subscribe here | External | Passing Juice |
| Subscribe to our newsletter | External | Passing Juice |
| Researchers | Internal | Passing Juice |
| Partners | Internal | Passing Juice |
| Investors | Internal | Passing Juice |
| Portfolio | Internal | Passing Juice |
| News and events | Internal | Passing Juice |
| Contact us | Internal | Passing Juice |
| Terms and conditions | Internal | Passing Juice |
| Privacy policy | Internal | Passing Juice |
| Modern slavery statement | Internal | Passing Juice |
| Section 172 | Internal | Passing Juice |
| Legal status | Internal | Passing Juice |
| Cookie policy | Internal | Passing Juice |
| Full disclosure of interactions with industry | External | Passing Juice |
SEO Keywords
Keywords Cloud
research translational cancer partners portfolio drug development news science start-up
Keywords Consistency
| Keyword | Content | Title | Keywords | Description | Headings |
|---|---|---|---|---|---|
| portfolio | 18 |  |
|
|
 |
| cancer | 15 | |
|
|
|
| start-up | 11 | |
|
|
|
| research | 9 | |
|
|
|
| science | 9 | |
|
|
|
Usability
Url
Domain : cancerresearchhorizons.com
Length : 26
Favicon
Great, your website has a favicon.
Printability
We could not find a Print-Friendly CSS.
Language
Good. Your declared language is en.
Dublin Core
This page does not take advantage of Dublin Core.
Document
Doctype
HTML 5
Encoding
Perfect. Your declared charset is UTF-8.
W3C Validity
Errors : 0
Warnings : 0
Email Privacy
Great no email address has been found in plain text!
Deprecated HTML
Great! We haven't found deprecated HTML tags in your HTML.
Speed Tips
|
Excellent, your website doesn't use nested tables. |
|
Too bad, your website is using inline styles. |
|
Great, your website has few CSS files. |
|
Perfect, your website has few JavaScript files. |
|
Perfect, your website takes advantage of gzip. |
Mobile
Mobile Optimization
|
Apple Icon |
|
Meta Viewport Tag |
|
Flash content |
Optimization
XML Sitemap
Great, your website has an XML sitemap.
| https://www.cancerresearchhorizons.com/sitemap.xml |
Robots.txt
https://cancerresearchhorizons.com/robots.txt
Great, your website has a robots.txt file.
Analytics
Missing
We didn't detect an analytics tool installed on this website.
Web analytics let you measure visitor activity on your website. You should have at least one analytics tool installed, but It can also be good to install a second in order to cross-check the data.
PageSpeed Insights
Device
Categories
Free SEO Testing Tool
Free SEO Testing Tool is a free SEO tool which provides you content analysis of the website.